Metastasis tumour suppressor-1 and the aggressiveness of prostate cancer cells

Experimental and Therapeutic Medicine

Volumn 2, Issue 1, 2011, Pages 157-162

  Mustafa, Noha ^a   Martin, Tracey A ^a   Jiang, Wen G ^a  

^a CARDIFF UNIVERSITY SCHOOL OF MEDICINE   (United Kingdom)

Author keywords

Cell growth; Cell migration; Metastasis tumour suppressor 1; Prostate cancer; Ribozyme transgenes

Indexed keywords

METASTASIS TUMOR SUPPRESSOR 1; TUMOR SUPPRESSOR PROTEIN; UNCLASSIFIED DRUG;

ARTICLE; CANCER CELL; CANCER GROWTH; CANCER INHIBITION; CELL ADHESION; CELL MIGRATION; GENE OVEREXPRESSION; GENE SILENCING; HUMAN; HUMAN CELL; MALE; METASTASIS; MIGRATION INHIBITION; PROSTATE CANCER; PROTEIN EXPRESSION; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION;

EID: 78751621184     PISSN: 17920981     EISSN: 17921015     Source Type: Journal    
DOI: 10.3892/etm.2010.184     Document Type: Article

References (17)

1. Ferlay J, Parkin D and Pisani P: Estimates of the worldwide incidence of 25 major cancers in 1990. Int J Cancer 80: 158-162, 1999.
2. Fidler IJ: The pathogenesis of cancer metastasis: the 'seed and soil' hypothesis revisited. Nat Rev Cancer 3: 453-458, 2003.
3. Folkman J: Toward an understanding of angiogenesis: search and discovery. Perspect Biol Med 29: 10-36, 1985.
4. Boyer B, Valles AM and Thiery JP: Model systems of carcinoma cell dispersion. Curr Top Microbiol Immunol 213: 179-194, 1996.
5. Stafford LJ, Vaidya KS and Welch DR: Metastasis suppressor genes in cancer. Int J Biochem Cell Biol 40: 874-891, 2008.
6. Lee YG, Macoska JA, Korenchuk S and Pienta KJ: MIM, a potential metastasis suppressor gene in bladder cancer. Neoplasia 4: 291-294, 2002.
7. Loberg RD, Neeley CK and Adam-Day LL: Differential expression analysis of MIM(MTSS1) splice variants and a functional role of MIMin prostate cancer cell biology. Int J Oncol 26: 1699-1705, 2005.
8. Callahan CA, Ofstad T, Horng T, Wang JK, Zhen HH, CoulombePA and Oro AE: MIM/BEG4, a Sonic hedgehog responsive gene that potentiates Gli-dependent transcription. Genes Dev 18: 2724-2729, 2004.
9. Mattila PK, Salminen M, Yamashiro T and Lappalainen P: Mouse MIM, a tissue specific regulator of cytoskeletal dynamics, interacts with ATP-actin monomers through its C-terminal WH2 domain. J Biol Chem 278: 8452-8459, 2003.
10. Lin J, Liu J, Wang Y, Zhu J, Zhou K, Smith N and Zhan X: Differential regulation of cortactin and N-WASP-mediated actin polymerization by missing in metastasis (MIM) protein. Oncogene 24: 2059-2066, 2005.
11. Utikal J, Gratchev A and Muller-Molinet I: The expression of metastasis suppressor MIM/MTSS1 is regulated by DNAmethylation. Int J Cancer 119: 2287-2293, 2006.
12. Parr Cand Jiang WG: Metastasis suppressor 1 (MTSS1) demonstrates prognostic value and anti-metastatic properties in breast cancer. Int J Cancer 45: 1673-1683, 2008.
13. Liu K, Wang G, Ding H, Chen Y, Yu G and Wang J: Down regulation of metastasis suppressor 1 (MTSS1) is associated with nodal metastasis and poor outcome in Chinese patients with gastric cancer. BMCCancer 10: 428, 2010
14. Bompard G, Sharp SJ, Freiss G and Machesky LM: Involvement of Rac in actin cytoskeleton rearrangements induced by MIM-B. J Cell Sci 118: 5393-5403, 2005.
15. Gonzalez-Quevedo R, Shoffer M, Horng L and Oro AE: Receptor tyrosine phosphatase-dependent cytoskeletal remodeling by the hedgehog-responsive gene MIM/BEG4. J Cell Biol 168: 453-463, 2005.
16. Wang Y, Liu J and Smith E: Downregulation of missing in metastasis gene (MIM) is associated with the progression of bladder transitional carcinomas. Cancer Invest 25: 79-86, 2007.
17. Ma S, Guan XY, Lee TK and Chan KW: Clinicopathological significance of missing in metastasis B expression in hepatocellular carcinoma. Hum Pathol 38: 1201-1206, 2007.